SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4214609177> ?p ?o ?g. }

Showing items 1 to 100 of ±123 with 100 items per page.

W4214609177 abstract "Summary The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant BA.2 has spread in many countries, replacing the earlier Omicron subvariant BA.1 and other variants. Here, using a cell culture infection assay, we quantified the intrinsic sensitivity of BA.2 and BA.1 compared with other variants of concern, Alpha, Gamma, and Delta, to five approved-neutralizing antibodies and antiviral drugs. Our assay revealed the diverse sensitivities of these variants to antibodies, including the loss of response of both BA.1 and BA.2 to casirivimab and of BA.1 to imdevimab. In contrast, EIDD-1931 and nirmatrelvir showed a more conserved activities to these variants. The viral response profile combined with mathematical analysis estimated differences in antiviral effects among variants in the clinical concentrations. These analyses provide essential evidence that gives insight into variant emergence’s impact on choosing optimal drug treatment." @default.
W4214609177 created "2022-03-02" @default.
W4214609177 creator A5009766303 @default.
W4214609177 creator A5011893599 @default.
W4214609177 creator A5013766979 @default.
W4214609177 creator A5015106160 @default.
W4214609177 creator A5034895510 @default.
W4214609177 creator A5035312362 @default.
W4214609177 creator A5040256695 @default.
W4214609177 creator A5046356018 @default.
W4214609177 creator A5054715839 @default.
W4214609177 creator A5054895255 @default.
W4214609177 creator A5056458565 @default.
W4214609177 creator A5059866115 @default.
W4214609177 creator A5061684783 @default.
W4214609177 creator A5066612748 @default.
W4214609177 creator A5069473183 @default.
W4214609177 creator A5080172780 @default.
W4214609177 creator A5082154089 @default.
W4214609177 creator A5082452145 @default.
W4214609177 creator A5083766528 @default.
W4214609177 creator A5086911881 @default.
W4214609177 creator A5088073393 @default.
W4214609177 creator A5090385951 @default.
W4214609177 creator A5091085788 @default.
W4214609177 date "2022-02-28" @default.
W4214609177 modified "2023-10-16" @default.
W4214609177 title "Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2" @default.
W4214609177 cites W1999749052 @default.
W4214609177 cites W2523085454 @default.
W4214609177 cites W3010955108 @default.
W4214609177 cites W3149537966 @default.
W4214609177 cites W4200488608 @default.
W4214609177 cites W4206993475 @default.
W4214609177 cites W4220807057 @default.
W4214609177 cites W4220904663 @default.
W4214609177 cites W4221072241 @default.
W4214609177 cites W4221116249 @default.
W4214609177 cites W4225590988 @default.
W4214609177 cites W4225691034 @default.
W4214609177 cites W4226023710 @default.
W4214609177 cites W4226087845 @default.
W4214609177 cites W4226164088 @default.
W4214609177 doi "https://doi.org/10.1101/2022.02.27.482147" @default.
W4214609177 hasPublicationYear "2022" @default.
W4214609177 type Work @default.
W4214609177 citedByCount "3" @default.
W4214609177 countsByYear W42146091772022 @default.
W4214609177 crossrefType "posted-content" @default.
W4214609177 hasAuthorship W4214609177A5009766303 @default.
W4214609177 hasAuthorship W4214609177A5011893599 @default.
W4214609177 hasAuthorship W4214609177A5013766979 @default.
W4214609177 hasAuthorship W4214609177A5015106160 @default.
W4214609177 hasAuthorship W4214609177A5034895510 @default.
W4214609177 hasAuthorship W4214609177A5035312362 @default.
W4214609177 hasAuthorship W4214609177A5040256695 @default.
W4214609177 hasAuthorship W4214609177A5046356018 @default.
W4214609177 hasAuthorship W4214609177A5054715839 @default.
W4214609177 hasAuthorship W4214609177A5054895255 @default.
W4214609177 hasAuthorship W4214609177A5056458565 @default.
W4214609177 hasAuthorship W4214609177A5059866115 @default.
W4214609177 hasAuthorship W4214609177A5061684783 @default.
W4214609177 hasAuthorship W4214609177A5066612748 @default.
W4214609177 hasAuthorship W4214609177A5069473183 @default.
W4214609177 hasAuthorship W4214609177A5080172780 @default.
W4214609177 hasAuthorship W4214609177A5082154089 @default.
W4214609177 hasAuthorship W4214609177A5082452145 @default.
W4214609177 hasAuthorship W4214609177A5083766528 @default.
W4214609177 hasAuthorship W4214609177A5086911881 @default.
W4214609177 hasAuthorship W4214609177A5088073393 @default.
W4214609177 hasAuthorship W4214609177A5090385951 @default.
W4214609177 hasAuthorship W4214609177A5091085788 @default.
W4214609177 hasBestOaLocation W42146091771 @default.
W4214609177 hasConcept C126322002 @default.
W4214609177 hasConcept C159047783 @default.
W4214609177 hasConcept C159654299 @default.
W4214609177 hasConcept C203014093 @default.
W4214609177 hasConcept C2522874641 @default.
W4214609177 hasConcept C2779134260 @default.
W4214609177 hasConcept C2779261636 @default.
W4214609177 hasConcept C2780035454 @default.
W4214609177 hasConcept C3007834351 @default.
W4214609177 hasConcept C3008058167 @default.
W4214609177 hasConcept C3018913218 @default.
W4214609177 hasConcept C3020491458 @default.
W4214609177 hasConcept C3020505244 @default.
W4214609177 hasConcept C524204448 @default.
W4214609177 hasConcept C71924100 @default.
W4214609177 hasConcept C86803240 @default.
W4214609177 hasConcept C98274493 @default.
W4214609177 hasConceptScore W4214609177C126322002 @default.
W4214609177 hasConceptScore W4214609177C159047783 @default.
W4214609177 hasConceptScore W4214609177C159654299 @default.
W4214609177 hasConceptScore W4214609177C203014093 @default.
W4214609177 hasConceptScore W4214609177C2522874641 @default.
W4214609177 hasConceptScore W4214609177C2779134260 @default.
W4214609177 hasConceptScore W4214609177C2779261636 @default.
W4214609177 hasConceptScore W4214609177C2780035454 @default.
W4214609177 hasConceptScore W4214609177C3007834351 @default.
W4214609177 hasConceptScore W4214609177C3008058167 @default.